Visium Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CS
O
Visium Asset Management's XBI Position: Q1 2016 in Review
Visium Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2016, closing a stake of 9,770 shares — an estimated $685K sold.
Visium Asset Management first reported a position in XBI in Q4 2014 and held it in 2 quarters. The position peaked at $685K in Q4 2015. 195 funds tracked by Wall St. Rank hold XBI as of Q1 2016.
- Visium Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2016 after selling out during the quarter.
- Visium Asset Management sold 9,770 State Street SPDR S&P Biotech ETF shares in Q1 2016, an estimated $685K.
- Visium Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2014 and held it in 2 quarters.
- Visium Asset Management's State Street SPDR S&P Biotech ETF position peaked at $685K in Q4 2015.
- 195 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2016.
Based on Visium Asset Management's 13F filing for Q1 2016, filed 16 May 2016.